Why the study?
The 2021 ESC guidelines updated recommendation classes and emphasized that cardiac devices do not contraindicate MRI, prompting a detailed review of required qualifications and device programming.
Is magnetic resonance imaging safe in patients with implanted electronic cardiac devices according to the 2021 ESC guidelines?
Is magnetic resonance imaging safe in patients with implanted electronic cardiac devices according to the 2021 ESC guidelines?
The 2021 ESC guidelines clarify that MRI is not contraindicated in patients with typical cardiac implantable electronic devices and provide detailed recommendations for safe performance.
May support updated ESC MRI recommendations for device patients; leaves open need for confirmatory trials.
<ns3:p>For over a decade, implantable electrotherapy devices have been available which allow — under certain conditions — diagnostic magnetic resonance imaging (MRI) tests to be performed. Detailed recommendations for the performance of these tests have been published in the latest guidelines by the European Society of Cardiology (ESC). The latest guidelines, compared to the 2013 recommendations, changed the recommendation class for MRI examinations. They strongly emphasised that the presence of a typical pacing system, cardioverter-defibrillator or resynchronization system, does not constitute a contraindication to MRI diagnostics. The guidelines also indicate that under certain conditions, such tests are safe and should be performed. This article presents detailed recommendations of the qualifications required for an MRI and the programming devices recommended by the ESC.</ns3:p>
No takes yet. Share an insight, caveat, or question.
Świerżyńska et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: